First Time Loading...
T

Tongyang Pile Inc
KOSDAQ:228340

Watchlist Manager
Tongyang Pile Inc
KOSDAQ:228340
Watchlist
Price: 2 250 KRW -0.66% Market Closed
Updated: Jun 10, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

135.3B
+3%
Assets
Growth Rates:
1 Year
+5%
3 Years
+11%
5 Years
-9%
7 Years
-28%
10 Years
-
7.2B
+69%
Liabilities
Growth Rates:
1 Year
+11%
3 Years
+8%
5 Years
-32%
7 Years
-84%
10 Years
-
128.1B
+0.9%
Equity
Growth Rates:
1 Year
+4%
3 Years
+11%
5 Years
-7%
7 Years
-11%
10 Years
-

Balance Sheet Decomposition
Tongyang Pile Inc

135.3B
Assets
7.2B
Liabilities
135.3B
Assets
7.2B
Liabilities
Current Assets 79.4B
Cash & Short-Term Investments 53.1B
Receivables 19.7B
Other Current Assets 6.7B
Non-Current Assets 55.9B
Long-Term Investments 57m
PP&E 50B
Intangibles 271.7m
Other Non-Current Assets 5.6B
Current Liabilities 7.2B
Accounts Payable 3.9B
Other Current Liabilities 3.2B
Non-Current Liabilities 38.5m
Long-Term Debt 38.5m

Balance Sheet
Tongyang Pile Inc

Rotate your device to view
Balance Sheet
Currency: KRW
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
9 621
30 343
56 997
48 001
47 152
11 768
21 406
6 441
10 318
3 987
Cash Equivalents
9 621
30 343
56 997
48 001
47 152
11 768
21 406
6 441
10 318
3 987
Short-Term Investments
0
0
0
0
0
25 195
25 280
40 754
40 009
49 086
Total Receivables
26 476
30 009
35 683
18 508
11 799
17 703
11 954
11 834
14 430
19 679
Accounts Receivables
26 039
29 556
35 656
18 003
8 738
17 437
11 707
11 736
14 430
19 280
Other Receivables
437
453
27
505
3 061
266
247
97
0
398
Inventory
4 663
2 280
3 500
5 126
6 297
4 855
3 697
6 860
6 661
6 648
Other Current Assets
18
17
5 633
5 611
5 588
5 565
12
12
14
16
Total Current Assets
40 778
62 649
101 813
77 246
70 835
65 086
62 349
65 901
71 432
79 416
PP&E Net
63 721
64 137
57 838
56 066
55 747
53 165
53 784
51 454
50 942
49 966
PP&E Gross
0
0
57 838
56 066
55 747
53 165
53 784
51 454
50 942
49 966
Accumulated Depreciation
0
0
9 992
12 668
15 263
17 965
20 614
23 010
24 832
27 068
Intangible Assets
3
3
152
115
78
42
6
272
272
272
Goodwill
29 510
29 510
24 429
20 533
14 060
0
0
0
0
0
Note Receivable
275
0
0
0
0
625
582
0
0
0
Long-Term Investments
6 227
4 719
2 224
2 115
2 069
1 981
68
84
57
57
Other Long-Term Assets
2 573
2 090
2 294
3 620
5 338
9 055
5 516
8 314
6 710
5 568
Other Assets
29 510
29 510
24 429
20 533
14 060
0
0
0
0
0
Total Assets
143 087
N/A
163 108
+14%
188 750
+16%
159 696
-15%
148 126
-7%
129 954
-12%
122 305
-6%
126 025
+3%
129 413
+3%
135 279
+5%
Liabilities
Accounts Payable
10 908
7 141
7 729
6 586
3 248
3 910
4 057
5 431
3 354
3 923
Accrued Liabilities
165
142
46
0
0
0
0
0
0
0
Short-Term Debt
37 000
36 000
25 000
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
48
49
13
221
112
Other Current Liabilities
10 166
11 233
12 281
6 216
7 356
3 688
2 555
2 553
2 761
3 124
Total Current Liabilities
58 239
54 516
45 056
12 802
10 603
7 646
6 661
7 997
6 336
7 159
Long-Term Debt
33 000
33 000
0
0
0
62
13
0
162
38
Other Liabilities
1 104
0
0
0
0
0
0
0
0
0
Total Liabilities
92 343
N/A
87 516
-5%
45 056
-49%
12 802
-72%
10 603
-17%
7 708
-27%
6 673
-13%
7 997
+20%
6 498
-19%
7 197
+11%
Equity
Common Stock
410
8 000
10 000
10 000
10 000
10 000
10 000
10 000
10 000
10 000
Retained Earnings
11 673
36 438
64 906
68 151
58 776
43 527
36 924
39 308
44 215
49 382
Additional Paid In Capital
38 660
31 070
68 693
68 693
68 693
68 693
68 693
68 693
68 693
68 693
Other Equity
2
85
94
50
53
25
14
27
6
6
Total Equity
50 744
N/A
75 592
+49%
143 694
+90%
146 894
+2%
137 523
-6%
122 246
-11%
115 632
-5%
118 028
+2%
122 914
+4%
128 082
+4%
Total Liabilities & Equity
143 087
N/A
163 108
+14%
188 750
+16%
159 696
-15%
148 126
-7%
129 954
-12%
122 305
-6%
126 025
+3%
129 413
+3%
135 279
+5%
Shares Outstanding
Common Shares Outstanding
1
16
20
20
20
20
20
20
20
20

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 146,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.